Last month, a 13 year old with Hodgkins disease, one of the most treatment-responsive cancers known, ran away to Mexico and was reported by the news media to be considering alternative treatment.
FDA’s Goodman urges transparency
June 15, 2009
5:10 pm
FDA chief scientist Jesse Goodman, recently named acting deputy commissioner for scientific and medical programs, said in May that he has been struck at how the public sees much of the government as less than transparent, “But FDA, I think is particularly opaque at times.”
Hamburg: Judge the agency on public health
June 15, 2009
5:06 pm
FDA commissioner Margaret Hamburg and principal deputy commissioner Joshua Sharfstein said in a June 11 New England Journal of Medicine “Perspective” column that the “ultimate measure of FDA’s success should reflect its fundamental goals and go beyond such intermediate measures as the number of facilities inspected or drugs approved.”
As I see it: Reorganizing the FDA means sweeping changes
Whether or not Congress elects to reorganize the FDA, the Obama Administration’s new leadership team at the agency vows sweeping changes are on the way, from drug safety to more transparency in everything the agency does.
The Office of Compliance and Biologics Quality (OCBQ) in the FDA’s Center for Biologics Evaluation and Research (CBER) has sent a warning letter to Baxter regarding the company’s promotional material for Tisseel general surgery brochure.
Cegedim Dendrite inked a three-year agreement with Sanofi-Aventis to provide Mobile Intelligence CRM solution to over 20,000 users across 28 countries including the US, France and Japan.
Contract sales firm PDI and The Medical Affairs Company (TMAC) signed an agreement aligning their respective services with the goal of providing clients with a more complete set of field-based commercialization solutions.
The Coalition for Healthcare Communication said it doesn’t oppose ACCME’s proposal to set up an independent entity for disbursal of CME funding—provided CME providers don’t have to pay for it.
“Pharmacists’ Facebook” to offer news, CE and community
For the second year in a row, members of the AMA House of Delegates sent back policy proposals tightening the organization’s rules regarding continuing medical education.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix